<DOC>
	<DOC>NCT00636844</DOC>
	<brief_summary>To identify patients that are at risk of heart damage after receiving chemotherapy (adriamycin).</brief_summary>
	<brief_title>Detection of Chemotherapy Induced Cardiotoxicity</brief_title>
	<detailed_description>To identify patients at risk of development of heart damage after receiving chemotherapy by obtaining the genetic profile of those who show: elevation of troponin, left ventricular systolic and diastolic dysfunction, and pro-oxidant stress markers.</detailed_description>
	<mesh_term>Cardiotoxicity</mesh_term>
	<criteria>undergoing anthracycline and/or trastuzumab therapy for the first time abnormal ventricular ejection fraction past history of, or active cardiac disease including: MI, CHF, angina, arrhythmia requiring medication, valvular disease, uncontrolled systemic hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>chemotherapy, cardiotoxicity</keyword>
</DOC>